Vitrolife AB (publ) (STO:VITR)

Vitrolife AB Revenue

Vitrolife AB had revenue of 884.00M SEK in the quarter ending September 30, 2026, with 5.87% growth. This brings the company's total for the last twelve months to 3.44B, down -1.91% year-over-year. In the year 2025, Vitrolife AB had annual revenue of 3.44B, down -4.68%. That makes Vitrolife AB the 13,449th largest company in the world by revenue and 169th in Sweden.

• Revenue: 3.44B
• Revenue Growth: -1.91%
• P/S Ratio: 4.50
• Revenue / Employee: 3.16M
• Employees: 1,088
• Market Cap: 15.64B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Genetics 1.39B 40.4%
• Consumables 1.37B 39.8%
• Technologies 684.00M 19.9%

By Geography

Chart

• EMEA 1.30B 37.8%
• Americas 1.14B 33.2%
• APAC 997.00M 29.0%

Fiscal year ended Dec 31, 2025 See the full Vitrolife AB breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	3.44B	-169.00M	-4.68%
Dec 31, 2024	3.61B	97.00M	2.76%
Dec 31, 2023	3.51B	278.00M	8.60%
Dec 31, 2022	3.23B	1.55B	92.39%
Dec 31, 2021	1.68B	435.43M	34.96%

Data Sources: S&P Global Market Intelligence and Fiscal.ai Last updated: Oct 22, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company. Revenue segment and geography data is provided by Fiscal.ai.

Update frequency:

Quarterly

Last checked:

Nov 3, 2026

Data Sources Report a data error